Literature DB >> 27471892

Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study.

Luke Macyszyn1, Mark Attiah1, Tracy S Ma1, Zarina Ali1, Ryan Faught1, Alisha Hossain1, Karen Man1, Hiren Patel1, Rosanna Sobota1, Eric L Zager1, Sherman C Stein1.   

Abstract

OBJECTIVE Moyamoya disease (MMD) is a chronic cerebrovascular disease that can lead to devastating neurological outcomes. Surgical intervention is the definitive treatment, with direct, indirect, and combined revascularization procedures currently employed by surgeons. The optimal surgical approach, however, remains unclear. In this decision analysis, the authors compared the effectiveness of revascularization procedures in both adult and pediatric patients with MMD. METHODS A comprehensive literature search was performed for studies of MMD. Using complication and success rates from the literature, the authors constructed a decision analysis model for treatment using a direct and indirect revascularization technique. Utility values for the various outcomes and complications were extracted from the literature examining preferences in similar clinical conditions. Sensitivity analysis was performed. RESULTS A structured literature search yielded 33 studies involving 4197 cases. Cases were divided into adult and pediatric populations. These were further subdivided into 3 different treatment groups: indirect, direct, and combined revascularization procedures. In the pediatric population at 5- and 10-year follow-up, there was no significant difference between indirect and combination procedures, but both were superior to direct revascularization. In adults at 4-year follow-up, indirect was superior to direct revascularization. CONCLUSIONS In the absence of factors that dictate a specific approach, the present decision analysis suggests that direct revascularization procedures are inferior in terms of quality-adjusted life years in both adults at 4 years and children at 5 and 10 years postoperatively, respectively. These findings were statistically significant (p < 0.001 in all cases), suggesting that indirect and combination procedures may offer optimal results at long-term follow-up.

Entities:  

Keywords:  MMD = moyamoya disease; QALY = quality-adjusted life year; QOL = quality of life; decision analysis; direct; indirect; moyamoya; revascularization; vascular disorders

Mesh:

Year:  2016        PMID: 27471892     DOI: 10.3171/2015.8.JNS15504

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Time Course of Neoangiogenesis After Indirect Bypass Surgery for Moyamoya Disease : Comparison of Short-term and Long-term Follow-up Angiography.

Authors:  Yahui Zhao; Junlin Lu; Qian Zhang; Yan Zhang; Dong Zhang; Rong Wang; Yuanli Zhao
Journal:  Clin Neuroradiol       Date:  2018-12-03       Impact factor: 3.649

2.  High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.

Authors:  Jiaxi Li; Yahui Zhao; Meng Zhao; Penghui Cao; Xingju Liu; Hao Ren; Dong Zhang; Yan Zhang; Rong Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2019-06-15       Impact factor: 3.042

3.  Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.

Authors:  Xiang Guo; Xuexia Yuan; Lingyun Gao; Yueqin Chen; Hao Yu; Weijian Chen; Yunjun Yang; Zhen Chong; Zhanguo Sun; Feng Jin; Deguo Liu
Journal:  Eur Radiol       Date:  2021-05-06       Impact factor: 5.315

4.  Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures.

Authors:  Jinbing Zhao; Hongyi Liu; Yuanjie Zou; Wenbin Zhang; Shengxue He
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

5.  Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study.

Authors:  Yahui Zhao; Junlin Lu; Shaochen Yu; Jiaxi Li; Xiaofeng Deng; Yan Zhang; Dong Zhang; Rong Wang; Hao Wang; Yuanli Zhao
Journal:  Front Neurol       Date:  2019-07-31       Impact factor: 4.003

6.  The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya.

Authors:  Xiang-Yang Bao; Yan-Na Fan; Qian-Nan Wang; Xiao-Peng Wang; Ri-Miao Yang; Zheng-Xing Zou; Qian Zhang; De-Sheng Li; Lian Duan; Xin-Guang Yu
Journal:  Front Neurol       Date:  2022-04-26       Impact factor: 4.003

7.  Current trends in pediatric moyamoya: a survey of international practitioners.

Authors:  Harishchandra Lalgudi Srinivasan; Moran Hausman-Kedem; Edward R Smith; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2021-03-10       Impact factor: 1.475

Review 8.  Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?

Authors:  Ignazio G Vetrano; Anna Bersano; Isabella Canavero; Francesco Restelli; Gabriella Raccuia; Elisa F Ciceri; Giuseppe Faragò; Andrea Gioppo; Morgan Broggi; Marco Schiariti; Laura Gatti; Paolo Ferroli; Francesco Acerbi
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

Review 9.  Pediatric Stroke: Overview and Recent Updates.

Authors:  Mary Hollist; Katherine Au; Larry Morgan; Padmashri A Shetty; Riddhi Rane; Abraham Hollist; Angela Amaniampong; Batool F Kirmani
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.